Atlas Trials

Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)

Clinical trial NCT04858867 · UNKNOWN

Trial details

NCT number
NCT04858867
Sponsor
Leiden University Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Differentiated Thyroid Cancer
Start date
2022-01-10
Primary completion
2025-01-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.